肾透明细胞癌细胞系中NOTCH1调控PTEN/PI3K/AKT信号通路促进肿瘤进展

刘尚文; 黄庆波; 艾青; 朱鸣阳; 张旭

肾透明细胞癌细胞系中NOTCH1调控PTEN/PI3K/AKT信号通路促进肿瘤进展

- 1. 解放军303医院泌尿外科(南宁, 530021);
- 2. 解放军总医院泌尿外科

详细信息

通讯作者: 刘尚文,E-mail:liusw_657410@126.com

中图分类号: R737.11

收稿日期: 2013-01-20

NOTCH1 promotes the pathogenesis of clear-cell renal-cell carcinoma by regulating the pathway of PTEN/PI3K/AKT in vitro

- 1. Department of Urology, Chinese PLA 303 Hosipital, Nanning, 530021, China;
- 2. Department of Urology, Chinese PLA General Hosipital

More Information

Corresponding author: LIU Shangwen, E-mail: liusw_657410@126.com

Received Date: 20 January 2013

摘要

摘要: 目的：研究NOTCH1在肾透明细胞癌细胞系中的生物功能及其对PTEN/PI3K/AKT信号通路的调控。方法：在肾透明细胞癌细胞系Caki-2及人肾小管上皮细胞系HKC中沉默NOTCH1，检测其对细胞增殖，细胞周期，凋亡以及肿瘤细胞侵袭和迁徙能力的影响。Western-blot 和qrt-PCR检测HES1，PTEN，AKT（p-S473）蛋白及mRNA的变化。结果：在两株细胞中，沉默NOTCH1均能抑制细胞生长，促进细胞周期阻滞，抑制肿瘤细胞的侵袭和迁徙。沉默NOTCH1引起HES1与AKT（p-S473）蛋白下降，PTEN的蛋白及mRNA水平明显升高。沉默HES1引起PTEN蛋白及mRNA升高。结论：在肾透明细胞癌细胞系中，过度活化的NOTCH1通过调节PTEN/PI3K/AKT信号通路起促癌作用，这为肾透明细胞癌的治疗提供了新的治疗策略。
- 肾透明细胞癌 /
- PTEN /
- PI3K/AKT信号通路 /
- NOTCH1信号
Abstract: Objective: Although NOTCH1 plays a wide-ranging role in controlling cell fate, differentiation and development, the pathological roles of NOTCH1 in clear-cell renal-cell carcinoma(CCRCC) are still unclear. In this study, the biological function of NOTCH1 was examined and the interaction of NOTCH1 with the phosphatase and tensin homologue deleted on chromosome 10 (PTEN)/phosphatidylinositol 3-kinase (PI3K)/AKT pathway was investigated in vitro.Method: The effects of NOTCH1 signaling pathway on cells proliferation, apoptosis, invasion and migration were detected by MTS assay, flow cytometry analyses and transwell chamber assay respectively. In addition, the alteration of NOTCH1, HES1, PTEN, AKT(phosphorylation at Ser473)in CCRCC cell line(Caki-2) and human normal kidney tubule epithelial cell line (HKC) were analyzed by Western blot and qrt-PCR, before and after transfected with siRNA against NOTCH1. Result: NOTCH1 signaling cascade was constitutively active in human CCRCC cell lines. Blocking NOTCH1 signaling resulted in the attenuation of proliferation, invasion and migration, as well as PTEN up-regulation with decreased AKT phosphorylation. Conclusion: Our findings indicated that the expression of NOTCH1 receptors was upregulated and NOTCH1 could regulates PTEN expression and the activity of the PI3K/AKT pathway via HES1 in CCRCC. This might provide the basis for the design of new therapeutic strategies for CCRCC.
- clear-cell renal-cell carcinoma /
- PTEN /
- PI3K/AKT pathway /
- NOTCH1 signalling

HTML全文

参考文献(15)

[1]	Zbar B, Klausner R, Linehan W M. Studying cancer families to identify kidney cancer genes[J]. Annu Rev Med, 2003, 54:217-233.
[2]	Motzer R J, Hutson T E, Tomczak P, et al. Sunitinib versus interferon-alfa in metastatic renal-cell carcinoma[J]. N Engl J Med, 2007, 356:115-124.
[3]	Miele L, Golde T, Osborne B. Notch signaling in cancer[J]. Curr Mol Med, 2006, 6:905-918.
[4]	Osaki M, Oshimura M, Ito H. PI3K-Akt pathway:its functions and alterations in human cancer[J]. Apoptosis, 2004, 9:667-676.
[5]	Aster J C, Pear W S, Blacklow S C. NOTCH Signaling in Leukemia[J]. Annu Rev Pathol 2007 Annu Rev Pathol, 2008, 3:587-613.
[6]	Grabher C, von Boehmer H, Look A T. NOTCH 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia[J]. Nat Rev Cancer, 2006, 6:347-359.
[7]	Ai Q, Ma X, Huang Q, et al. High-level expression of Notch1 increased the risk of metastasis in T1 stage clear cell renal cell carcinoma[J]. PLoS One, 2012, 7:e35022.
[8]	Sjölund J, Johansson M, Manna S, et al. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo[J]. J Clin Invest, 2008, 118:217-228.
[9]	Sourbier C, Lindner V, Lang H, et al. The Phosphoinositide 3-Kinase/Akt Pathway:A New Target in Human Renal Cell Carcinoma Therapy[J]. Cancer Res, 2006, 66:5130-5142.
[10]	Velickovic M, Delahunt B, McIver B, et al. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis[J]. ModPathol, 2002, 15:479-485.
[11]	Shin Lee J, Seok Kim H, Bok Kim Y, et al. Expression of PTEN in Renal Cell Carcinoma and Its Relation to Tumor Behavior and Growth[J]. J Sur Oncol, 2003, 84:166-172.
[12]	Ciofani M, Zúñiga-Pflücker J C. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism[J]. Nat Immunol, 2005, 6:881-888.
[13]	Palomero T, Dominguez M, Ferrando A A. The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia[J]. Cell Cycle, 2008, 7:965-970.
[14]	Wang Z, Banerjee S, Li Y, et al. Down-regulation of NOTCH-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells[J]. Cancer Res, 2006, 66:2778-2784.
[15]	Wu F, Stutzman A, Mo Y Y. NOTCH signaling and its role in breast cancer[J]. Front Biosci, 2007, 12:4370-4383.